Michael Jeng
Academic Appointments
- Associate Professor - Med Center Line, Pediatrics - Hematology/Oncology
Contact Information
-
Clinical Offices
Pediatric Hematology/Oncology 770 Welch Rd Ste 261 Palo Alto, CA 94304 Tel Work (650) 497-8953 Fax (650) 725-3219Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Administrative Contact Stephanie Colombo Administrative Associate, III Email Tel Work 650-723-5535Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Hematology, Pediatric
- Pediatric Hematology-Oncology
Honors and Awards
- St. Jude Teaching Award, LeBonheur Children's Hospital (2002)
Professional Education
| Fellowship: | Children's Hospital Oakland, CA (1999) |
| Board Certification: | Pediatric Hematology-Oncology, American Board of Pediatrics (2000) |
| Residency: | Children's Memorial Hospital, IL (1996) |
| Medical Education: | Case Western Reserve University School of Medicine, OH (1993) |
| B.A.: | Bowdoin College, Biology, Philosophy (1989) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Novartis Pharmaceuticals |
Scientific Focus
Current Research Interests
Research interests include pediatric hematologic disorders, such as bone marrow failure disorders, sickle cell disease, hemophilia, and thalassemia. Current clinical research includes transfusion related iron overload.
Clinical Trials
Publications
- Adherence to study medication and visits: data from the BABY HUG trial. Pediatr Blood Cancer. 2010; (2): 260-4
- Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms. Br J Haematol. 2010; (2): 268-73
- Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia. Haemophilia. 2009; (6): 1272-80
- Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Pediatr Blood Cancer. 2009; (1): 97-9
- Gene expression and pathway analysis of immune thrombocytopenic purpura. Br J Haematol. 2008; (1): 99-103
Help